Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
Journal
Gut and Liver
Journal Volume
16
Journal Issue
1
Pages
8-18
Date Issued
2022
Author(s)
for the Taiwan Gastrointestinal Disease
Helicobacter Consortium
Abstract
infection. The selection of appropriate antibiotics may be guided by susceptibility testing or empirically by medication history. Tailored therapy guided by susceptibility testing or genotypic resistance is recommended whenever possible. However, properly designed empirical therapy based on prior medication history (i.e., avoid the reuse of clarithromycin or levofloxacin empirically) is an acceptable alternative to tailored therapy after considering accessibility, cost, and the preference of the patient.
SDGs
Publisher
Editorial Office of Gut and Liver
Type
review